LAVA Therapeutics N.V.

NASDAQ:LVTX

0.9752 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 6.76919.3915.353.7470
Cost of Revenue 3.4820015.7018.347
Gross Profit 3.28719.3915.35-11.954-8.347
Gross Profit Ratio 0.48611-3.190
Reseach & Development Expenses 33.81440.10536.94515.7018.347
General & Administrative Expenses 12.72614.12412.0182.7191.236
Selling & Marketing Expenses 00000
SG&A 12.72614.12412.0182.7191.236
Other Expenses 00000
Operating Expenses 46.5451.30646.9233.5881.254
Operating Income -43.253-34.838-43.613-14.673-9.583
Operating Income Ratio -6.39-1.797-8.152-3.9160
Total Other Income Expenses Net 1.5583.181.415-1.211-0.104
Income Before Tax -41.695-31.658-42.198-15.884-9.687
Income Before Tax Ratio -6.16-1.633-7.887-4.2390
Income Tax Expense 0.2790.2490.1570.0430
Net Income -41.974-31.907-42.355-15.927-9.687
Net Income Ratio -6.201-1.645-7.917-4.2510
EPS -1.57-1.23-2.14-39.9-21.65
EPS Diluted -1.57-1.23-2.14-39.9-21.65
EBITDA -40.417-30.877-41.015-14.652-9.484
EBITDA Ratio -5.971-1.771-8.09-3.8590